Karolinska Development
An investment company that finances and supports innovative life science ventures.
KDEV | ST
Overview
Corporate Details
- ISIN(s):
- SE0002190850 (+1 more)
- LEI:
- 54930011ZA52NKO5W681
- Country:
- Sweden
- Address:
- Nanna Svartz väg 6A, 171 65 Solna
Description
Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-02-07 13:13 |
Rättelse av felskrivning i pressmeddelande om kallelse till extra bolagsstämma
|
Swedish | 100.3 KB | ||
| 2017-02-07 13:13 |
Correction of error in press release regarding convening notice to the EGM
|
English | 99.7 KB | ||
| 2017-02-06 22:07 |
Aktieägarna i Karolinska Development AB (publ) kallas till extra bolagsstämma
|
Swedish | 376.7 KB | ||
| 2017-02-06 22:07 |
Notice of Extraordinary General Meeting in Karolinska Development AB (publ)
|
English | 396.9 KB | ||
| 2016-11-23 07:50 | Swedish | 768.8 KB | |||
| 2016-11-23 07:50 | English | 878.0 KB | |||
| 2016-11-17 08:19 |
Karolinska Development – Delårsrapport för januari - september 2016, inbjudan t…
|
Swedish | 263.9 KB | ||
| 2016-11-17 08:00 |
Karolinska Development – Q3 2016 Interim Report - invitation to conference call…
|
English | 340.2 KB | ||
| 2016-11-03 08:00 |
Karolinska Development company Umecrine Cognition announces positive Phase 1 da…
|
English | 478.6 KB | ||
| 2016-11-03 08:00 |
Karolinska Developments bolag Umecrine Cognition meddelar positiva Fas 1-data m…
|
Swedish | 480.5 KB | ||
| 2016-09-30 09:00 |
Change of number of shares and votes in Karolinska Development
|
English | 102.2 KB | ||
| 2016-09-30 09:00 |
Ändring av antalet aktier och röster i Karolinska Development
|
Swedish | 102.3 KB | ||
| 2016-08-31 12:06 | Swedish | 749.7 KB | |||
| 2016-08-31 12:06 | English | 929.1 KB | |||
| 2016-08-29 11:44 |
Karolinska Development – Q2 2016 Interim Report - invitation to conference call…
|
English | 340.0 KB |
Automate Your Workflow. Get a real-time feed of all Karolinska Development filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Karolinska Development
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Karolinska Development via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-04 | Johan Dighed | Other | Buy | 35,000 | 56,350.00 SEK |
| 2023-03-27 | Johan Dighed | Other | Buy | 50,000 | 89,000.00 SEK |
| 2023-02-17 | Hans Christopher Karl Osvald Perbandt Toll | Other | Buy | 35,000 | 72,100.00 SEK |
| 2022-12-19 | Johan Dighed | Other | Buy | 50,000 | 83,500.00 SEK |
| 2022-09-30 | Johan Dighed | Other | Buy | 40,187 | 72,336.60 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,014 | 25,780.04 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 5,000 | 14,350.00 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,276 | 26,529.36 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 4,645 | 13,331.15 SEK |
| 2020-06-23 | Hans Lennart Rudolf Wigzell | Other | Buy | 39,702 | 111,562.62 SEK |
Peer Companies
